videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    isPremium
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

isPremium

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

first

order

upcoming

edges

CEO, Sweden

Claus Thestrup

Ascelia Pharma

Meet and ask questions to Deputy CEO Julie Waras Brogren from Ascelia Pharma on 21 May 2024 at 1:00 PM when he gives investors an update on Q1 2024.

You can already now sign up for the event and send in your questions. You don&#x2019;t have to participate live to send in questions for the event. Meet and ask questions to Deputy CEO Julie Waras Brogren from Ascelia Pharma on 21 May 2024 at 1:00 PM when she gives investors an update on Q1 2024. After the closing of Q1, Ascelia Pharma confirmed that SPARKLE image reading has been completed and expects headline results in first half of May 2024. Furthermore, the company announced that they have exercised the 2nd tranche of loan facility with Formue Nord Fokus A/S. Ascelia Pharma is a biotech company focused on orphan oncology treatments. They develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates &#x2013; Orviglance&#xae; (Mangoral) and Oncoral &#x2013; in clinical development. Ascelia Pharma has its global headquarters in Malm&#xf6;, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE) Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a DigitalIR/Corporate Visibility agreement./ Claus Thestrup 13.24 PM 23-04-2024.

HC Andersen Capital

Ascelia Pharma - What happened during Q1?

Herantis Pharma

Herantis Pharma Plc, Phase 1b biomarker data webcast

Novo Nordisk

NTG Nordic Transport Group

Genmab

Demant

Pandora

Carlsberg

Rockwool

HCA Morgenbørs 08/01 - Røde futures og fokus på kursmålsjusteringer

Shape Robotics

Vestas Wind Systems

A.P. Møller - Mærsk

Netcompany Group

HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus 

Roblon

Roblon – Præsentation af årsregnskabet for 2024/25

FLSmidth & Co.

HCA Morgenbørs 06/01 - Europæiske futures indikerer at vi forlænger Santa Claus rally'et

Recent videos